Urgent

Non-islet cell tumour hypoglycaemia

Hypoglycaemia · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Recurrent fasting hypoglycaemia from tumour secretion of incompletely processed IGF-2 (big IGF-2), typically with large mesenchymal or epithelial tumours.

Red flags

  • Severe / recurrent hypoglycaemia
  • Reduced conscious level
  • Large mediastinal / abdominal tumour
  • Seizures

Assessment

Differential diagnosis

  • Insulinoma
  • Sulfonylurea-induced hypoglycaemia
  • Adrenal insufficiency
  • Factitious insulin use
  • Critical illness / liver failure

Investigations

  • Capillary and laboratory glucose
  • Insulin, C-peptide, IGF-2:IGF-1 ratio during hypoglycaemia
  • Cortisol
  • Imaging for underlying tumour
  • Sulfonylurea screen

Management

  • Treat acute hypoglycaemia immediately
  • Confirm true hypoglycaemia with paired samples
  • Distinguish from insulinoma (low insulin/C-peptide here)
  • Search for and treat the underlying tumour
  • Prevent recurrence with frequent feeds / glucose support
  • Endocrinology and oncology referral

Drugs & doses

IV glucose for acute episodes
Corticosteroids or glucagon (specialist, to raise glucose)
Directed tumour therapy

Disposition

Admit; endocrinology + oncology.

Complications & pitfalls

  • Neuroglycopenic injury
  • Recurrent hypoglycaemia
  • Complications of the underlying tumour

Exam pearls

  • Low insulin and C-peptide with hypoglycaemia point away from insulinoma.
  • Tumour resection can cure the hypoglycaemia.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.